KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Inovio Pharmaceuticals (INO) Net Income - Minority (2019 - 2020)

Inovio Pharmaceuticals' Net Income - Minority history spans 2 years, with the latest figure at -$96269.0 for Q3 2020.

  • On a quarterly basis, Net Income - Minority changed N/A to -$96269.0 in Q3 2020 year-over-year; TTM through Sep 2020 was -$96269.0, a N/A change, with the full-year FY2019 number at -$2.0 million, changed N/A from a year prior.
  • Net Income - Minority hit -$96269.0 in Q3 2020 for Inovio Pharmaceuticals, roughly flat from -$96269.0 in the prior quarter.
  • Over the last five years, Net Income - Minority for INO hit a ceiling of -$96269.0 in Q2 2020 and a floor of -$2.0 million in Q4 2019.